GE Healthcare Expands AI, Digital and Imaging Solutions at #RSNA2020, Helping Shape Future of Healthcare in the COVID Era
29 November 2020 - 01:00PM
Business Wire
GE Healthcare today unveiled a slate of new intelligently
efficient solutions to help clinicians solve today’s two-part
challenge of delivering high quality care while managing greater
capacity and workflow issues, exacerbated by the impact of
COVID-19. Building on continuing investments in innovation and
digital health momentum, GE Healthcare is expanding its AI
offerings and Edison ecosystem, and also introducing breakthrough
imaging innovations that will help shape the future of
healthcare.
“COVID-19 has demonstrated the need for an adaptable and
digitized healthcare system that empowers clinicians with next
generation tools which would have otherwise taken years to develop
and adopt quickly, accelerating changes that would have otherwise
taken years to adopt,” said Kieran Murphy, president & CEO, GE
Healthcare. “At GE Healthcare, we remain committed to driving
innovation to achieve precision health and improve lives. This
includes continued investment in our Edison intelligence portfolio,
and also development of new imaging technologies to modernize
standards of care.”
At this year’s virtual #RSNA2020, GE Healthcare is highlighting
several new solutions that empower clinicians with future-looking
technologies to drive efficiencies and improve patient outcomes,
and address challenges related to COVID-19.
The Future is Now: raising the standard of care with
intelligent efficiency
In an era when care is largely focused on the acute effects of
COVID-19, healthcare’s challenges of cost, quality and access and
provider pressure to do more with less remains. Add physician
burnout - of which 64% of surveyed physicians said has intensified
during the pandemici - and the need for efficiency has never been
greater. “Like most heath systems, we were looking for system-wide
efficiencies even before the pandemic hit,” said Laurie Sebastiano,
MD, Section Chief of Ultrasound, St Luke's University Health
Network. “By working with GE Healthcare to standardize our fleet of
ultrasound systems across our 12-hospital network, we will drive
greater efficiency and consistency to our ultrasound users in the
Vascular, Radiology and Echocardiography departments. Our new
ultrasound equipment will help the technologist be more efficient
because these machines are designed to streamline their activity
and reduce clicks. Also, it will help the radiologist by bringing
in some of the numbers that we routinely dictate right into our
reports.”
- Photon counting CT with Prismatic Sensors AB’s patented Deep
Silicon detectors has the potential to further expand the
clinical capabilities of traditional CT when fully developed,
including the visualization of minute details of organ structures,
improved tissue characterization, more accurate material density
measurement (or quantification) and lower radiation doseii. GE
Healthcare’s acquisition of Prismatic Sensors signifies the
company’s continued investment in photon counting CT technology,
which has the potential to significantly increase clinical
performance for oncology, cardiology, neurology, and many other
clinical CT applicationsii.
- TrueFidelity for GSIiii has the potential to enhance
traditional GSI images with reduced image noiseiv, improved
contrast noise ratiov and low contrast detectabilityvi as well as
preferred noise texturevii. In turn, the technology has the
potential to enhance inherent GSI diagnostic benefits, such as
lesion detection, characterization and artifact reduction.
- Discovery MI Gen 2 is the is the only PET/CT system that
brings together the sensitivityviii of digital detection with the
innovative reconstruction technology available in CT: Deep Learning
Image Reconstruction for TrueFidelity CT Images. Using a dedicated
deep neural network to generate TrueFidelity CT Images, Discovery
MI Gen 2 has the potential to improve reading confidence in a wide
range of clinical applications such as head, whole body and
cardiovascular, for patients of all ages.
- AIR Recon DL is the MR industry’s first US FDA-cleared,
deep learning-based image reconstruction technology that works
across all anatomies. Available as an upgrade to installed base
systems and forward production across all 1.5T and 3.0T scannersix,
AIR Recon DL can help providers process the COVID-19 backlog faster
without compromising image quality. Early adopters are seeing
between 30-50 percent exam time reductions with AIR Recon DL, with
higher signal-to-noise ratios (SNR) and higher resolution.
- Allia IGS 7x is a completely redesigned image guided
therapy suite designed to be an assistant focusing on ergonomics,
ease-of-use and workflow efficiency. With just one click on the
personalized interfaces, the users can access their essential
functions to make it their room. Similarly, with the redesigned
C-arm making the controls more accessible, the assistant will
enable an optimized ergonomic setup for the user’s clinical needs,
even in complex working positions at the head, neck or left
side.
- LOGIQ E10 Series are high-end radiology ultrasound
systems that harness artificial intelligence (AI) technology to
drive workflow productivity. This series includes the new LOGIQ E10
leadership ultrasound system for radiology with a full suite of
advanced imaging tools and the new LOGIQ E10s ultrasound with
multi-purpose capabilities in a scalable configuration. Built on
the cutting-edge A to A digital platform, and using next generation
cSound Architecture to automatically deliver images of exceptional
uniformity, the LOGIQ E10 Series provides impressive imaging and
full-featured versatility so clinicians can scan and care for a
wide range of patients across a broad spectrum of conditions with
speed and precision.
- OEC 3Dxi is a new C-arm designed to deliver 3D and 2D
images presenting a large field of view to surgeons, integrating
seamlessly into existing surgical workflows for enhanced surgical
imaging precision and efficiency. OEC 3D features a 3D image
reconstruction engine designed to present surgeons with
high-resolution volume reconstructed CT-like images enabling
surgeons to visualize exactly where they are operating in 3D for
procedures where precision matters.
- Command Centers empower every care team with their own
real-time personal command center to optimize care progression,
protocol compliance, staffing and so much more. GE’s Command Center
software provides intuitive actionable information created from AI
applied to integrated data from Electronic Medical Record modules
and other systems.
Pandemic Disruption: tackling COVID-19 with trailblazing
technologies
Whether defining the disease, determining a diagnosis, or
observing the outcomes, COVID-19 is a disease of uncertainties.
While the unknowns are still being studied and assessed, the need
for health systems and healthcare providers to tackle and treat
COVID-19 is both urgent and ubiquitous. Trailblazing technologies
that launched prior to the pandemic, many of which are AI-powered,
have proven to help the medical community better understand,
triage, treat and manage COVID-19 and some of the resulting
long-term health effects of the virus. “In the present times, AI is
not a luxury, but a necessity for the high-quality patient care
we’re providing in the hospital,” said Amit Gupta, MD, Modality
Director of Diagnostic Radiography, University Hospitals Cleveland
Medical Center. “As we operate with limited staff, scarce
resources, and relying on residents’ support whenever we can, the
team must make split second decisions in emergency situations.
Critical Care Suite, the on-device AI solution that enables triage
of critical conditions such as pneumothorax, helps our residents
prioritize these types of patients.”
Here are a few examples of trailblazing technologies that are
being used to tackle COVID-19:
- Critical Care Suite 2.0xii features a new AI algorithm
to help clinicians assess Endotracheal Tube (ETT) placements, a
necessary and important step when ventilating critically ill
COVID-19 patients. The AI solution is one of five included in GE
Healthcare’s Critical Care Suite 2.0, an industry-first collection
of AI algorithms embedded on a mobile x-ray device for automated
measurements, case prioritization and quality control that can help
improve efficiency on the front lines.
- VenueGo features an adaptable take-anywhere design and
powerful AI-enabled auto tools that simplify complicated workflows
to help the clinician care for patients at the point of care. From
fast and automated assessments, like the AI-enhanced Auto B-line
Tool that quickly calculates the overall lung score for triage
decisions, to the fluid management and monitoring of pulmonary
conditions including those associated with COVID-19xiii, Venue Go
can help support the patient across all point of care areas and
clinical spaces.
- CT in a Boxxiv is an all-in-one portable CT solution
available to pop up scan centers and hospitals to enable fast CT
deployment using safe distancing measures and helping to minimize
contact with potential COVID-19 cases. With more than 100 installed
throughout the worldxiv, GE Healthcare’s CT in a Box solution is
helping to provide accelerated access to CT imaging in situations
requiring increased CT scansxv.
- Vscan Extend handheld, pocket-sized ultrasound system
empowers healthcare professionals to make focused assessments and
accelerate treatment decisions at the point of care. In the
COVID-19 environment, Vscan Extend can help manage patients with
respiratory conditions offering a dual-probe system that is simple
to use, easy cleanability and portability, and on-device
applications that support lung and cardiovascular ultrasound
exams.
- Thoracic Care Suitexvi harnesses the power of eight
artificial intelligence (AI) algorithms from Lunit Insight CXR to
help alleviate clinical strain due to COVID-19. The AI suite
quickly analyzes chest x-ray findings and flags abnormalities to
radiologists for review, including pneumonia, which may be
indicative of COVID-19xvii as well as tuberculosis, lung nodules,
and other radiological findings.
- The new Ultra Edition release of Vivid products includes
AI-based features which enable clinicians to quickly acquire more
repeatable exams consistently and extends Vivid’s well-established
strain-based functional assessment to the left atrium and right
ventricle. Evidence of right heart dysfunction—especially right
ventricular longitudinal strain on two-dimensional speckle-tracking
echocardiography—is tightly linked to higher mortality among
patients with COVID-19. Strain imaging is a particularly useful
tool for gauging myocardial function in this setting.
- The Mural Virtual Care Solution COVID-19 offering
integrates data from multiple systems and devices into a single
pane of glass to provide a real time (requires real time HL7 data
feed from clinical devices), comprehensive view of patients' status
and to give hospitals the ability to extend clinical capabilities
and resources by allowing visibility to at-risk and ventilated
patients while minimizing exposure to staff.
- CARESCAPE R860 is intuitively organized with workspace
views so parameters and measurements, such as respiratory rate and
tidal volume, as well as therapy controls are not buried in menus.
Additionally, GE Healthcare has provided ICU Ventilation User
Resources to help clinicians respond to surges in ventilated
COVID-19 patients and focus on delivering patient care.
- Diagnostic Cardiology helps with the assessment of
diagnostic ECG, which is critical in COVID-19 patients due to an
increased incidence of arrhythmias and prolonged QT. Recognition of
ST-elevated acute myocardial infarction needs to be done in the
presence of a variety complicating factors including myocarditis,
positive troponins and electrolyte abnormalities. See these
clinical topics covered in Diagnostic ECG Clinical Insights.
- Digital Expert is a remote technology training tool that
can be used by healthcare providers to help navigate the challenges
associated with a global pandemic by enabling virtual, live,
face-to-face instructor-led interactive clinical training sessions
using a mobile tablet. The technology provides individual users and
entire departments with convenient access to training, enabling
them to use equipment when it’s needed. Since COVID-19, Digital
Expert has contributed to a 40 percent increase in calls made
between customers and GE remote applications specialists and a 50
percent increase in the number of support hours provided to
customersxviii. Digital Expert is currently available with
Ultrasound, MR, X-Ray and Nuclear Workstation applications.
For more information on GE Healthcare and its intelligently
efficient solutions, visit the company’s virtual RSNA booth or
gehealthcare.com.
About GE Healthcare
GE Healthcare is the $16.7 billion healthcare business of GE
(NYSE: GE). As a leading global medical technology and digital
solutions innovator, GE Healthcare enables clinicians to make
faster, more informed decisions through intelligent devices, data
analytics, applications and services, supported by its Edison
intelligence platform. With over 100 years of healthcare industry
experience and around 50,000 employees globally, the company
operates at the center of an ecosystem working toward precision
health, digitizing healthcare, helping drive productivity and
improve outcomes for patients, providers, health systems and
researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights
for the latest news, or visit our website www.gehealthcare.com for
more information
i Physician Income Drops, Burnout Spikes Globally in Pandemic,
Medscape Medical News, Marcia Frellick, September 11, 2020. ii
Technology in development. Not for sale. Not cleared or approved by
the U.S. FDA or any other global regulator for commercial
availability. iii TrueFidelity for GSI is 510k pending at FDA, not
available sale in all regions. iv Demonstrated in testing using the
uniform section of the Catphan®600 with the CTP579 oval body
annulus comparing pixel standard deviation in images reconstructed
from the same raw data, at 0.625mm with DLIR‐H and ASiR‐V 50%. v
Demonstrated in testing using images of the CT ACR 464 Phantom
(Gammex) and its 25 mm low contrast cylinder reconstructed from the
same raw data with DLIR‐L, DILR-M, and DLIR-H and ASiR‐V 50%. vi
Evaluated using the body MITA CT IQ Low Contrast Phantom (CCT189,
the Phantom Laboratory) with the CTP579 oval body annulus and a
model observer with images reconstructed from the same raw data
with DLIR‐H and ASiR‐V 50%. vii As demonstrated in a clinical
evaluation consisting of 40 cases and 5 physicians, where each case
was reconstructed with both DLIR for GSI and ASiR-V and evaluated
by 3 of the physicians. In 88% of the reads, DLIR for GSI’s noise
texture was rated better than ASiR-V’s. viii Discovery MI Gen 2 has
the highest NEMA sensitivity in its class in the market, comparing
with common PET/CT systems with same or similar AFOV (based on
IMV’s Medical Information Division’s 2019 report as the
manufacturers representing more than 90% of the US Installed Base).
ix AIR Recon DL is not yet CE marked for 1.5T. Product may not be
available in all countries and regions and cannot be placed on the
market or put into service until it has been made to comply with
all required regulatory authorizations. x Allia IGS 7 is not yet CE
marked. Product may not be available in all countries and regions
and cannot be placed on the market or put into service until it has
been made to comply with all required regulatory authorizations. xi
510(k) pending at the FDA. Not for sale. Not cleared or approved by
other global regulators for commercial availability. xii Critical
Care Suite 2.0 is only available in the United States. Not cleared
or approved by the FDA. Distributed in accordance with FDA imaging
guidance regarding COVID-19 public health emergency. xiii Accessed
on 11/19/20:
https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/what-coronavirus-does-to-the-lungs.
xiv Available in select countries. Not available in all regions. xv
Rodgers, A et al. “The World Health Report 2002 Reducing Risks,
Promoting Healthy Life.” World Health Report, World Health
Organization, 2002,
https://www.who.int/whr/2002/en/whr02_en.pdf?ua=1. xvi Available in
select CE Mark countries. Not available in all regions. xvii
Provisional Death Counts for Coronavirus Disease (COVID-19).
Published June 12, 2020. Accessed June 12, 2020, from
https://www.cdc.gov/nchs/nvss/vsrr/covid19/index.htm. xviii GE
Healthcare Data on File.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201129005350/en/
Margaret Steinhafel Margaret.Steinhafel@ge.com +1 608 381
8829
General Electric (NYSE:GE)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
General Electric (NYSE:GE)
Historical Stock Chart
Von Mär 2023 bis Mär 2024